Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
21.70
-1.00 (-4.41%)
At close: Jul 2, 2024, 4:00 PM
21.71
+0.01 (0.05%)
After-hours: Jul 2, 2024, 7:00 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.02 billion as of July 2, 2024. Its market cap has increased by 26.34% in one year.
Market Cap
1.02B
Enterprise Value
700.14M
1-Year Change
26.34%
Ranking
Category
Stock Price
$21.70
Market Cap Chart
Since March 12, 2020, Enliven Therapeutics's market cap has increased from $244.90M to $1.02B, an increase of 316.78%. That is a compound annual growth rate of 39.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.02B | 78.94% |
| Dec 29, 2023 | 570.40M | 430.60% |
| Dec 30, 2022 | 107.50M | 81.90% |
| Dec 31, 2021 | 59.10M | -84.60% |
| Dec 31, 2020 | 383.80M | 56.72% |
| Mar 12, 2020 | 244.90M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 1.19B |
| Xencor | 1.17B |
| Verona Pharma | 1.12B |
| Prothena Corporation | 1.11B |
| AtriCure | 1.10B |
| 4D Molecular Therapeutics | 1.09B |
| Arcutis Biotherapeutics | 1.08B |
| Silk Road Medical | 1.07B |